Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours Β· Estimated delivery Aug 24 - Aug 29
Clinical trials showed tirzepatide achieves weight loss rates averaging 20-22 percentsubstantially higher than first-generation GLP-1 drugsmaking it a game-changing option for patients seeking maximum metabolic impact
Different administration methods for different goals: Oral or sublingual administration may be ideal for gut support and systemic effects, while injectable forms might be preferred for targeted musculoskeletal issues
Additionally, Ozempic slows gastric emptying, which means food remains in the stomach longer, promoting a feeling of fullness and reducing overall calorie intake
GLP-1 can act on the central GLP-1 receptors (especially the hypothalamus) and the central satiety center, causing a feeling of satiety and reducing food intake, thus achieving weight loss through appetite suppression
Market Dynamics Driver Rising Prevalence of Metabolic Disorders The main factor fueling the growth of the GLP-1 Autoinjectors and Pen Injectors market is the rise in the prevalence of Type 2 Diabetes and Obesity around the world
US$ 25.33
US$ 27.81
US$ 21.60
